GBCS
Price
$1.86
Change
-$0.00 (-0.00%)
Updated
Dec 11 closing price
JRSS
Price
$0.15
Change
-$0.02 (-11.76%)
Updated
Dec 18 closing price
Ad is loading...

GBCS vs JRSS

Header iconGBCS vs JRSS Comparison
Open Charts GBCS vs JRSSBanner chart's image
Selectis Health
Price$1.86
Change-$0.00 (-0.00%)
Volume$800
CapitalizationN/A
JRSIS Health Care
Price$0.15
Change-$0.02 (-11.76%)
Volume$385
CapitalizationN/A
GBCS vs JRSS Comparison Chart
Loading...
GBCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JRSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GBCS vs. JRSS commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBCS is a Hold and JRSS is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (GBCS: $1.86 vs. JRSS: $0.15)
Brand notoriety: GBCS and JRSS are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: GBCS: 76% vs. JRSS: 15%
Market capitalization -- GBCS: $15.34M vs. JRSS: $23.35M
GBCS [@Medical/Nursing Services] is valued at $15.34M. JRSS’s [@Medical/Nursing Services] market capitalization is $23.35M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $88.21B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $4.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GBCS’s FA Score shows that 1 FA rating(s) are green whileJRSS’s FA Score has 0 green FA rating(s).

  • GBCS’s FA Score: 1 green, 4 red.
  • JRSS’s FA Score: 0 green, 5 red.
According to our system of comparison, GBCS is a better buy in the long-term than JRSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GBCS’s TA Score shows that 4 TA indicator(s) are bullish while JRSS’s TA Score has 3 bullish TA indicator(s).

  • GBCS’s TA Score: 4 bullish, 3 bearish.
  • JRSS’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, both GBCS and JRSS are a good buy in the short-term.

Price Growth

GBCS (@Medical/Nursing Services) experienced а 0.00% price change this week, while JRSS (@Medical/Nursing Services) price change was -29.87% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -4.34%. For the same industry, the average monthly price growth was +1.30%, and the average quarterly price growth was +1.29%.

Industries' Descriptions

@Medical/Nursing Services (-4.34% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JRSS($23.3M) has a higher market cap than GBCS($15.3M). GBCS has higher P/E ratio than JRSS: GBCS (17.18) vs JRSS (0.36). GBCS YTD gains are higher at: -56.744 vs. JRSS (-80.682). JRSS has less debt than GBCS: JRSS (15.5K) vs GBCS (37.8M).
GBCSJRSSGBCS / JRSS
Capitalization15.3M23.3M66%
EBITDA3.23MN/A-
Gain YTD-56.744-80.68270%
P/E Ratio17.180.364,807%
Revenue35MN/A-
Total Cash2.98MN/A-
Total Debt37.8M15.5K243,871%
FUNDAMENTALS RATINGS
GBCS vs JRSS: Fundamental Ratings
GBCS
JRSS
OUTLOOK RATING
1..100
9598
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
4764
P/E GROWTH RATING
1..100
2399
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JRSS's Valuation (90) in the null industry is in the same range as GBCS (95). This means that JRSS’s stock grew similarly to GBCS’s over the last 12 months.

JRSS's Profit vs Risk Rating (100) in the null industry is in the same range as GBCS (100). This means that JRSS’s stock grew similarly to GBCS’s over the last 12 months.

JRSS's SMR Rating (98) in the null industry is in the same range as GBCS (99). This means that JRSS’s stock grew similarly to GBCS’s over the last 12 months.

GBCS's Price Growth Rating (47) in the null industry is in the same range as JRSS (64). This means that GBCS’s stock grew similarly to JRSS’s over the last 12 months.

GBCS's P/E Growth Rating (23) in the null industry is significantly better than the same rating for JRSS (99). This means that GBCS’s stock grew significantly faster than JRSS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GBCSJRSS
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
63%
MACD
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
40%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
69%
View a ticker or compare two or three
Ad is loading...
GBCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JRSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EQUL27.12N/A
N/A
IQ Engender Equality ETF
FLCO21.33-0.01
-0.07%
Franklin Investment Grade Corporate ETF
SGOL25.24-0.08
-0.32%
abrdn Physical Gold Shares ETF
XUSP42.19-0.22
-0.52%
Innovator Uncapped Accelerated US Eq ETF
SPUU156.99-1.29
-0.81%
Direxion Daily S&P 500® Bull 2X ETF

GBCS and

Correlation & Price change

A.I.dvisor tells us that GBCS and JRSS have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GBCS and JRSS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBCS
1D Price
Change %
GBCS100%
N/A
JRSS - GBCS
21%
Poorly correlated
N/A
PIII - GBCS
10%
Poorly correlated
-1.32%
PHCI - GBCS
2%
Poorly correlated
N/A
AIRS - GBCS
2%
Poorly correlated
+5.18%
DCGO - GBCS
2%
Poorly correlated
-2.23%
More

JRSS and

Correlation & Price change

A.I.dvisor tells us that JRSS and GBCS have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JRSS and GBCS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JRSS
1D Price
Change %
JRSS100%
N/A
GBCS - JRSS
21%
Poorly correlated
N/A
SNDA - JRSS
20%
Poorly correlated
+1.07%
LTGHY - JRSS
3%
Poorly correlated
-2.36%
NVLPF - JRSS
3%
Poorly correlated
N/A
ORPEF - JRSS
0%
Poorly correlated
N/A
More